BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15657354)

  • 21. Heterogeneous methylation of the O(6)-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines.
    Danam RP; Howell SR; Remack JS; Brent TP
    Int J Oncol; 2001 Jun; 18(6):1187-93. PubMed ID: 11351250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
    Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
    Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
    Claus R; Fliegauf M; Stock M; Duque JA; Kolanczyk M; Lübbert M
    J Leukoc Biol; 2006 Dec; 80(6):1462-72. PubMed ID: 17000900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells].
    Deng Y; Lu X; Liu L; Li T; Zhang Y; Guo X; Yu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):810-3. PubMed ID: 25108432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure.
    Yan Y; Kluz T; Zhang P; Chen HB; Costa M
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):272-7. PubMed ID: 12902198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
    Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
    Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I; Wischnewski F; Pantel K; Schwarzenbach H
    BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma.
    Yang J; Zhu XB; He LX; Gu ZW; Jin MZ; Ji WY
    Oncol Lett; 2015 Jan; 9(1):35-42. PubMed ID: 25452816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
    Stimson KM; Vertino PM
    J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the human O(6)-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300.
    Bhakat KK; Mitra S
    J Biol Chem; 2000 Nov; 275(44):34197-204. PubMed ID: 10942771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
    Meng CF; Su B; Li W
    Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of the putative tumor-suppressor genes DCC, p51/63 and O6-methylguanine-DNA methyltransferase (MGMT) and loss of their expressions in cell lines of hematological malignancies.
    Nakayama K; Inokuchi K; Dan K
    J Nippon Med Sch; 2005 Oct; 72(5):270-7. PubMed ID: 16247226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
    Mossman D; Scott RJ
    PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
    Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
    Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO; Chen HJ; Tian H; Edenberg HJ
    Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types.
    Bacolod MD; Barany F
    Curr Cancer Drug Targets; 2021; 21(4):360-374. PubMed ID: 33535955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.